VIR Biotechnology

https://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-proceeding-two-clinical-development-candidates

VIR Biotechnology has identified multiple human monoclonal antibody (mAb) development candidates that neutralize SARS-CoV-2, the virus responsible for COVID-19

Rankings by

Национальный рейтинг

315th

in United States

Региональный рейтинг

356th

in North America and Caribbean

Глобальный рейтинг

862nd

worldwide

Loading startups...